Clinical Trials Browser

Active not recruiting × cediranib × Tumor-Agnostic × Clear all

NCT00750841 2026-05-19

Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours

Phase 1 Active not recruiting

Neoplasm Metastasis